首页> Cancer immunology, immunotherapy : CII> Association of immune-related pneumonitis with the presence of preexisting interstitial lung disease in patients with non-small lung cancer receiving anti-programmed cell death 1 antibody.

Association of immune-related pneumonitis with the presence of preexisting interstitial lung disease in patients with non-small lung cancer receiving anti-programmed cell death 1 antibody.

导出 OA

翻译打印收藏纠错

第一作者： Ryota,Shibaki

第一单位： Department of Thoracic Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.;Department of Pulmonary Medicine and Oncology, Wakayama Medical University, Wakayama, Japan.

作者： Ryota,Shibaki ^[1] ; Shuji,Murakami ^[2] ; Yuji,Matsumoto ^[3] ; Tatsuya,Yoshida ^[3] ; Yasushi,Goto ^[3] ; Shintaro,Kanda ^[3] ; Hidehito,Horinouchi ^[3] ; Yutaka,Fujiwara ^[3] ; Nobuyuki,Yamamoto ^[4] ; Masahiko,Kusumoto ^[5] ; Noboru,Yamamoto ^[3] ; Yuichiro,Ohe ^[3]

作者单位： Department of Thoracic Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.;Department of Pulmonary Medicine and Oncology, Wakayama Medical University, Wakayama, Japan. ^[1] Department of Thoracic Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan. shumurak@ncc.go.jp. ^[2] Department of Thoracic Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan. ^[3] Department of Pulmonary Medicine and Oncology, Wakayama Medical University, Wakayama, Japan. ^[4] Department of Diagnostic Radiology, National Cancer Center Hospital, Tokyo, Japan. ^[5]

关键词 Anti-PD-1 antibody Immune checkpoint inhibitor Immune-related adverse event Interstitial lung disease Non-small cell lung cancer Pneumonitis